The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics
Abstract
Oxazolidinone antibiotics, an important new class of synthetic antibacterials, inhibit protein synthesis by interfering with ribosomal function. The exact site and mechanism of oxazolidinone action has not been elucidated. Although genetic data pointed to the ribosomal peptidyltransferase as the primary site of drug action, some biochemical studies conducted in vitro suggested interaction with different regions of the ribosome. These inconsistent observations obtained in vivo and in vitro have complicated the understanding of oxazolidinone action. To localize the site of oxazolidinone action in the living cell, we have cross-linked a photoactive drug analog to its target in intact, actively growing Staphylococcus aureus. The oxazolidinone cross-linked specifically to 23 S rRNA, tRNA, and two polypeptides. The site of cross-linking to 23 S rRNA was mapped to the universally conserved A-2602. Polypeptides cross-linked were the ribosomal protein L27, whose N terminus may reach the peptidyltransferase center, and LepA, a protein homologous to translation factors. Only ribosome-associated LepA, but not free protein, was cross-linked, indicating that LepA was cross-linked by the ribosome-bound antibiotic. The evidence suggests that a specific oxazolidinone binding site is formed in the translating ribosome in the immediate vicinity of the peptidyltransferase center.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Linezolid binds to the conserved nucleotide A2602, which is part of the V domain of the 23S rRNA in the 50S subunit, and to two proteins on the same subunit: the ribosomal protein L27, whose N-end is closely adjacent to the active center of peptidyl transferase, and the LepA [93].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Structural Basis of Ribosome Activity in Peptide Bond Synthesis
Nissen, P., Hansen, J., Ban, N., Moore, P. B., & Steitz, T. A. (2000) · Science · doi:10.1126/science.289.5481.920 · Cited by 2,269
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950
Pactamycin resistance mutations in functional sites of 16 S rRNA
Mankin, A. S. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1387 · Cited by 47
Self-citation
Research works printed but not linked: 54
- Schlunzen, 2001, Nature, 413, 814, 10.1038/35101544 · DOI · Paper page
- Ramakrishnan, 2002, Cell, 108, 557, 10.1016/S0092-8674(02)00619-0 · DOI · Paper page
- Ford, 1996, Antimicrob. Agents Chemother., 40, 1508, 10.1128/AAC.40.6.1508 · DOI
- Eustice, 1988, Biochem. Biophys. Res. Commun., 150, 965, 10.1016/0006-291X(88)90723-1 · doi:10.1016/0006-291x(88)90723-1
- Eustice, 1988, Antimicrob. Agents Chemother., 32, 1218, 10.1128/AAC.32.8.1218 · DOI
- Shinabarger, 1997, Antimicrob. Agents Chemother., 41, 2132, 10.1128/AAC.41.10.2132 · DOI · Paper page
- Swaney, 1998, Antimicrob. Agents Chemother., 42, 3251, 10.1128/AAC.42.12.3251 · DOI · Paper page
- Patel, 2001, J. Biol. Chem., 276, 37199, 10.1074/jbc.M102966200 · doi:10.1074/jbc.m102966200
- Stevens, 2002, Clin. Infect. Dis., 34, 1481, 10.1086/340353 · DOI · Paper page
- Swaney, 1998, Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Kloss, 1999, J. Mol. Biol., 294, 93, 10.1006/jmbi.1999.3247 · DOI · Paper page
- Xiong, 2000, J. Bacteriol., 182, 5325, 10.1128/JB.182.19.5325-5331.2000 · DOI · Paper page
- Prystowsky, 2001, Antimicrob. Agents Chemother., 45, 2154, 10.1128/AAC.45.7.2154-2156.2001 · DOI · Paper page
- Matassova, 1999, RNA (N. Y.), 5, 939, 10.1017/S1355838299990210 · DOI
- Aoki, 2002, Antimicrob. Agents Chemother., 46, 1080, 10.1128/AAC.46.4.1080-1085.2002 · DOI
- Shinabarger, 1999, Exp. Opin. Investig. Drugs, 8, 1195, 10.1517/13543784.8.8.1195 · DOI · Paper page
- Burghardt, 1998, FEBS Lett., 425, 40, 10.1016/S0014-5793(98)00194-X · DOI
- Thompson, 2002, J. Mol. Biol., 322, 273, 10.1016/S0022-2836(02)00784-2 · DOI
- Zhou, 2002, Antimicrob. Agents Chemother., 46, 625, 10.1128/AAC.46.3.625-629.2002 · doi:10.1128/aac.46.3.625-629.2002
- Moazed, 1987, Biochimie (Paris), 69, 879, 10.1016/0300-9084(87)90215-X · DOI · Paper page
- Moazed, 1987, Nature, 327, 389, 10.1038/327389a0 · DOI · Paper page
- Brickner, 1996, J. Med. Chem., 39, 673, 10.1021/jm9509556 · DOI · Paper page
- Barbachyn, 1998, Adv. Exp. Med. Biol., 456, 219, 10.1007/978-1-4615-4897-3_12 · DOI
- Cannone, J. J., Subramanian, S., Schnare, M. N., Collett, J. R., D'Souza, L. M., Du, Y., Feng, B., Lin, N., Madabusi, L. V., Muller, K. M., Pande, N., Shang, Z., Yu, N., and Gutell, R. R. BMC Bioinformatics (2002) 3, http://www.biomedcentral.com/content/pdf/1471-2105-3-2.pdf · DOI · Paper page
- Greenwood, 1963, Biochem. J., 89, 114, 10.1042/bj0890114 · DOI · Paper page
- Kreiswirth, 1983, Nature, 305, 709, 10.1038/305709a0 · DOI · Paper page
- Donis-Keller, 1979, Nucleic Acids Res., 7, 179, 10.1093/nar/7.1.179 · DOI · Paper page
- Mankin, 1981, FEBS Lett., 131, 253, 10.1016/0014-5793(81)80378-X · doi:10.1016/0014-5793(81)80378-x
- Dontsova, 1991, EMBO J., 10, 2613, 10.1002/j.1460-2075.1991.tb07803.x · DOI
- Barritault, 1976, Eur. J. Biochem., 63, 131, 10.1111/j.1432-1033.1976.tb10215.x · DOI · Paper page
- Shevchenko, 1996, Anal. Chem., 68, 850, 10.1021/ac950914h · DOI · Paper page
- Cooperman, 1988, Methods Enzymol., 164, 523, 10.1016/S0076-6879(88)64067-5 · doi:10.1016/s0076-6879(88)64067-5
- Schenk, 1992, FEMS Microbiol. Lett., 94, 133, 10.1111/j.1574-6968.1992.tb05302.x · DOI · Paper page
- Rinke-Appel, 1991, EMBO J., 10, 2195, 10.1002/j.1460-2075.1991.tb07755.x · DOI
- Wower, 1989, Proc. Natl. Acad. Sci. U. S. A., 86, 5232, 10.1073/pnas.86.14.5232 · DOI
- Wower, 1995, Biochem. Cell Biol., 73, 1041, 10.1139/o95-111 · DOI
- Wower, 2000, J. Biol. Chem., 275, 37887, 10.1074/jbc.M005031200 · DOI
- Sonenberg, 1973, Proc. Natl. Acad. Sci. U. S. A., 70, 1423, 10.1073/pnas.70.5.1423 · DOI
- Tejedor, 1985, J. Antimicrob. Chemother., 16, 53, 10.1093/jac/16.suppl_A.53 · DOI
- Arévalo, 1989, J. Med. Chem., 32, 2200, 10.1021/jm00129a027 · doi:10.1021/jm00129a027
- Bischof, 1994, J. Biol. Chem., 269, 18315, 10.1016/S0021-9258(17)32308-6 · DOI
- Nicholson, 1982, Biochemistry, 21, 3797, 10.1021/bi00259a013 · DOI
- Ban, 2000, Science, 289, 905, 10.1126/science.289.5481.905 · DOI · Paper page
- Harms, 2001, Cell, 107, 679, 10.1016/S0092-8674(01)00546-3 · DOI · Paper page
- Wower, 1998, J. Biol. Chem., 273, 19847, 10.1074/jbc.273.31.19847 · DOI
- Champney, 2002, Curr. Microbiol., 44, 350, 10.1007/s00284-001-0023-7 · doi:10.1007/s00284-001-0023-7
- Caldon, 2001, Mol. Microbiol., 41, 289, 10.1046/j.1365-2958.2001.02536.x · DOI
- Lin, 1997, Antimicrob. Agents Chemother., 41, 2127, 10.1128/AAC.41.10.2127 · DOI · Paper page
- Monro, 1969, Nature, 222, 356, 10.1038/222356a0 · DOI
- Porse, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 9003, 10.1073/pnas.96.16.9003 · DOI
- Weisblum, 1995, Antimicrob. Agents Chemother., 39, 797, 10.1128/AAC.39.4.797 · DOI · Paper page
- Moazed, 1989, Cell, 57, 585, 10.1016/0092-8674(89)90128-1 · DOI · Paper page
- Polacek, 2003, Mol. Cell, 11, 103, 10.1016/S1097-2765(02)00825-0 · DOI
- Hansen, 2002, Proc. Natl. Acad. Sci. U. S. A., 99, 11670, 10.1073/pnas.172404099 · DOI · Paper page
Cited by
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
Antituberculosis drugs: Ten years of research
Janin, Y. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.030 · Cited by 485
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?
Guzman Prieto, A. M., van Schaik, W., Rogers, M. R. C., Coque, T. M., Baquero, F., Corander, J., & Willems, R. J. L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00788 · Cited by 385
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
Long, K. S., & Vester, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05702-11 · Cited by 375
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
“The drug binding site is composed of rRNA residues that form the inner shell of the peptidyl transferase active site (Colca et al., 2003; Skripkin et al., 2005; Leach et al., 2007).”
BackgroundSelf-citationColca, J. R., McDonald, W. G., Waldon, D. J., Leone, J. W., Lull, J. M., Bannow, C. A., Lund, E. T., & Mathews, W. R. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00424.2003 · Cited by 338
Self-citationReck, F., Zhou, F., Girardot, M., Kern, G., Eyermann, C. J., Hales, N. J., Ramsay, R. R., & Gravestock, M. B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0400810 · Cited by 332
The A-Z of bacterial translation inhibitors
Wilson, D. N. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903307311 · Cited by 322
Inhibitors of protein biosynthesis
(2006) · Biochemistry and Molecular Biology of Antimicrobial Drug Action · doi:10.1007/0-387-27566-5_5 · Cited by 318
Wilson, D. N., Schluenzen, F., Harms, J. M., Starosta, A. L., Connell, S. R., & Fucini, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804276105 · Cited by 318
The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria
Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D., Xiong, L., & Mankin, A. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.005 · Cited by 276
Self-citationInhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones
McKee, E. E., Ferguson, M., Bentley, A. T., & Marks, T. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01411-05 · Cited by 270
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
Sacchettini, J. C., Rubin, E. J., & Freundlich, J. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1816 · Cited by 256
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
Aoki, W., & Ueda, M. (2013) · Pharmaceuticals · doi:10.3390/ph6081055 · Cited by 252
Mendes, R. E., Deshpande, L. M., & Jones, R. N. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.04.002 · Cited by 221
The bacterial translation stress response.
Starosta, A. L., Lassak, J., Jung, K., & Wilson, D. N. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12083 · Cited by 210
Phylogenetic distribution of translational GTPases in bacteria
Margus, T., Remm, M., & Tenson, T. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-15 · Cited by 115
“LepA crosslinks with ribosome-bound oxazolidinone antibiotics indicating that it can bind to the ribosome [71].”
Background
Metadata
- Authors
- Colca, J. R., McDonald, W. G., Waldon, D. J., Thomasco, L. M., Gadwood, R. C., Lund, E. T., Cavey, G. S., Mathews, W. R., Adams, L. D., Cecil, E. T., Pearson, J. D., Bock, J. H., Mott, J. E., Shinabarger, D. L., Xiong, L., & Mankin, A. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 24
- Pages
- 21972-21979
- ISSN
- 0021-9258
- Cited by
- 139
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6323 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.